DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China · Delayed Price · Currency is CNY 19.82
+0.15 (0.76%)
Mar 6, 2026, 3:00 PM CST
35.29% (1Y)
| Market Cap | 22.57B +40.2% |
| Revenue (ttm) | 26.83B +1.1% |
| Net Income | 1.14B +33.8% |
| EPS | 1.01 +35.1% |
| Shares Out | 1.14B |
| PE Ratio | 19.59 |
| Forward PE | 17.56 |
| Dividend | 0.68 (3.43%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 3,305,358 |
| Average Volume | 5,607,988 |
| Open | 19.67 |
| Previous Close | 19.67 |
| Day's Range | 19.55 - 19.92 |
| 52-Week Range | 14.45 - 21.78 |
| Beta | 0.64 |
| RSI | 55.35 |
| Earnings Date | Apr 24, 2026 |